Urigen Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Date: February 17, 2015
Pages: 24
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: U591585A9F9EN
Leaflet:

Download PDF Leaflet

Urigen Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Urigen Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Urigen Pharmaceuticals, Inc. (Urigen) is a specialty pharmaceutical company that develops and commercializes therapeutic products for urological disorders. The company’s research and development activities are aimed at developing innovative products for amelioration of urethritis, painful bladder syndrome (PBS), nocturia and over active bladder (OAB). Its pipeline includes URG101, being developed for the painful bladder syndrome/interstitial cystitis. The company has licensed URG101, a proprietary combination therapy for the relief of pain of bladder. It made several agreements and collaboration with the industry player to expand the Scope of its research operations. Urigen is headquartered in San Francisco, the US.

As a part of its growth strategy, the company seeks partnerships in the EU, Japan, Latin America and Asia for the development of its product candidate, URG101.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Urigen Pharmaceuticals, Inc. - Key Facts
Urigen Pharmaceuticals, Inc. - Key Employees
Urigen Pharmaceuticals, Inc. - Key Employee Biographies
Urigen Pharmaceuticals, Inc. - Major Products and Services
Urigen Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data
Urigen Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Urigen Pharmaceuticals, Inc., Pipeline Products by Development Phase
Urigen Pharmaceuticals, Inc. - History
Urigen Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Urigen Pharmaceuticals, Inc. - Business Description
Urigen Pharmaceuticals, Inc. - Corporate Strategy
Urigen Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Urigen Pharmaceuticals, Inc. - Strengths
Strength - Intellectual Property
Strength - Potential Proprietary Product Candidates
Urigen Pharmaceuticals, Inc. - Weaknesses
Weakness - Lack of Marketed Products
Weakness - Reliance on the Third Parties
Urigen Pharmaceuticals, Inc. - Opportunities
Opportunity - Changing Demographics
Opportunity - Rising Healthcare Expenditures: the US
Opportunity - Market Potential: PBS
Urigen Pharmaceuticals, Inc. - Threats
Threat - Government Regulation
Threat - Uncertain R&D Outcomes
Threat - Tough Competitive Market
Urigen Pharmaceuticals, Inc. - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Urigen Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Urigen Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Urigen Pharmaceuticals, Inc., Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Urigen Pharmaceuticals, Inc., Key Facts
Urigen Pharmaceuticals, Inc., Key Employees
Urigen Pharmaceuticals, Inc., Key Employee Biographies
Urigen Pharmaceuticals, Inc., Major Products and Services
Urigen Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area
Urigen Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage
Urigen Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase
Urigen Pharmaceuticals, Inc., History
Urigen Pharmaceuticals, Inc., Key Competitors
Urigen Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Urigen Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Urigen Pharmaceuticals, Inc., Recent Deals Summary

LIST OF FIGURES

Urigen Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Urigen Pharmaceuticals, Inc., Pipeline Products by Development Phase
Urigen Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Urigen Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Urigen Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: